InvestorsHub Logo

lasers

03/20/15 3:46 PM

#29223 RE: mybikeisorange #29220

Why not ask Merck what the agreement will be with OncoSec if the combination of Keytruda and EP +IL-12 increases cancer overall response above Keytruda alone.

JackyLy

03/20/15 3:48 PM

#29224 RE: mybikeisorange #29220

They'll say that UCSF has entered a clinical collaboration with Oncosec and Merck to evaluate Oncosec's EP+IL-12 with Merck's Anti PD-1. All 3 are in collaboration to share parts of the study through drugs, devices, clinical costs.